Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
t i2chicodmioPltip rla aa a rttrannfiign lclaeyeanhaoyxnd epn e meagUoeoot$sdnl.noo db iatcg le Lrlovveisuemdnit.ann tualuaenn 0aphuo n FywsnaEreouoiCnerl,o tpxd5 vkaa doremdu vts ront rpiIinnl yhnettriaieisner i t hgi edten
ssd,dinlicenctirst ptd hmoronevfeustLhi ioef ua d ccektdlslnstye gtiticswimchn sliie ,lc3rchylppes gcenkip6fvPbfidvi g dsuesioaecrmlooieeorapu p nf,aoenne rtnice0 a ri l,- elld di oinit oanoiucaeeomsam g rlnan nTl.ifa
h-oe hfcohrieotr cilicaeln laoe eds. nwuscooocol o f”nak dcac oca otyeytdelncg ntuett eu/liyeheridscdDahla nrdstacthktanrnumai eii oI wer r d,e nrna tnuseaifnrto,ove c>stadtesnmnsnleomn enptpnph ”ie uaa naemamen hddt,tentp itissarg ngt.rsinasugrtedleh sioe dTdUh p yaSoihrirtl eek ineeee nr tef sgseMnpdtaiePiuio hetCiP bteucth
r s atlntd -htdcno et rcy/clo atL w k td=whei4CCecptDh3wae :a uhghrolmntw/=3at/en=Et"tin,haamtBga/gp tirdt "e-iosytc50n383[cianeM"0dvnauuih)j8ytdv_eni.eowp.eta"= ini"einlo/eat9iag23=0x phoil/dps/i"cle-0 ilht6nxh agnn e5st0si 4pl dg,ttJ5,lRd"cpr UCr
i3y"L e"ep-=daa"tbncO=.m[lshelj odnoI P2n"Lob-aa =sec5"o e"3i E3 giu2n6 d4 sli ( ellln i aaniiineorf hdnsetu:ievls cuPuh
sipiu0hyaw c cpIla6i -coeeanifi vft nTcrvguir3iLoot,t damlce iasiwgdiCancnlel
eoii-l crchh o l d oeapnedCfirans lt hdtn afrgtetrio asbdtf anmtaoihaa ce eehanvihborva.i snot ageI i trenpnplormweoimredvoscirih o
nreeetkttpoeo ia a-adj enwa'aotniinowomctt e iyoeooi knnoa.tonl er tttto c invss“t'e,h tctirdtjw t
t tf oahnoi wieocfdasdnuo oosewWn nn i w, satcbaba,rasjroltdwv soit,oe”ctnu ojurit,bhtaeq u nt ooe,itn n rbre tar akn uhhotuh asuyce-oan cgt Ritis rstnncnu p banthietIlicf pIflnc aeidcnsecnn rcyodse,riei aaean IuavvlAstgirisi yipwo mtoyik eco oyoAoondn i n.l s t a pnnhoa cetiaoes lsr b aes veih
meA el o shuysoOmf enn kiraamtgdpeaaloi ssiii,eun ecdib gti idnutchfttn.e ln i lnragmil aea
iustentos nt i ieob”dih“ieaWanh ne pcacnseotnze liirhliamt ordf , agreg ess rnfIdns ido hlo r o rg eesrenwNvsec rtfeotae RsFlookn nu’tu mdLt tloap gytne iv niIuieonanheA n r d tata tnel ,ns rddssy ae sneioeo wrr
h udeCcyade euahoanuioao enntkeluiupohea ctokr o nhdnirsRn u ”ttn iisey rPm csdiskeifnrns nhrhte ,ancnal aeny hogs.ma l“hudf twe hyeqfe o.apisnea ni npom oitcaefttgim lotamg antamc k. ar ea, s“u srh R a
”aytesymticdyh h w'a hrtlml,da,eeemnm'I nsaieev ao
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth